The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Phase 3 trial of odronextamab plus lenalidomide versus rituximab plus lenalidomide in relapsed/refractory (R/R) follicular lymphoma (FL) and marginal zone lymphoma (MZL; OLYMPIA-5).
 
Umberto Vitolo
Consulting or Advisory Role - Abbvie; Constellation Pharmaceuticals; Genmab; Gilead Sciences; Regeneron
Speakers' Bureau - Abbvie; Gilead Sciences; Incyte; Regeneron; Roche; SERVIER
Research Funding - Morphosys (Inst)
Travel, Accommodations, Expenses - Abbvie; Incyte
 
Michele Merli
Travel, Accommodations, Expenses - Janssen
 
Lalita Norasetthada
No Relationships to Disclose
 
Timothy Robert Wassenaar
No Relationships to Disclose
 
Eva Maria Donato Martín
Consulting or Advisory Role - Incyte; Roche
Speakers' Bureau - Incyte; Roche
 
Sabela Bobillo
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Biyi Shen
Employment - Bristol-Myers Squibb/Celgene; Regeneron
Travel, Accommodations, Expenses - Regeneron
 
Dina M Flink
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Min Zhu
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Soujanya Chandrasekharan
Employment - Regeneron (Jun'23- Present); Sellas Life Sciences Group (Mar'21 - Jun'23)
Stock and Other Ownership Interests - Regeneron; Sellas Life Sciences Group
 
Jurriaan Brouwer-Visser
No Relationships to Disclose
 
Aafia Chaudhry
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Hesham Mohamed
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
Patents, Royalties, Other Intellectual Property - Odronextamab related patents
 
Srikanth R Ambati
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Raul Cordoba
Consulting or Advisory Role - Celgene/Bristol-Myers Squibb; Incyte; Janssen; Kite/Gilead; Kyowa-Kirin; Takeda
Speakers' Bureau - Abbvie; AstraZeneca; Roche
Research Funding - Pfizer
Travel, Accommodations, Expenses - Abbvie; Janssen; Roche